QQ客服 官方微博 反馈留言

浏览/检索结果: 共15条，第1-10条 帮助 限定条件 发表日期：2016    专题：山东大学    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 MEG3 regulates cell cycle progression via control of P53 expression in gastric cancer 期刊论文 INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 卷号: 9, 期号: 7, 页码: 6887-6895 作者:  Yang, Xiaomin;  Ren, Hao;  Wei, Ran;  Zhang, Xin;  Zhang, Xiaoli 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/16 Gastric cancer  lncRNA-MEG3  P53  cell cycle  therapeutic target   The roles of microRNAs related with progression and metastasis in human cancers 期刊论文 TUMOR BIOLOGY, 2016, 卷号: 37, 期号: 12, 页码: 15383-15397 作者:  Liu, Hai-Ting;  Gao, Peng 收藏  |  浏览/下载：1/0  |  提交时间：2019/12/16 microRNA  EMT  EMT-TFs  Cancer  Metastasis  Progression   TIMP1 is a prognostic marker for the progression and metastasis of colon cancer through FAK-PI3K/AKT and MAPK pathway 期刊论文 JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2016, 卷号: 35 作者:  Song, Guohe;  Xu, Shifeng;  Zhang, Hong;  Wang, Yupeng;  Xiao, Chao 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/16 TIMP1  Colon cancer  Prognosis  Tumorigenesis   Molecular regulation of galectin-expression and therapeutic implication in cancer progression 期刊论文 Biomedicine and Pharmacotherapy, 2016, 卷号: 78, 页码: 165-171 作者:  Wang L.;  Guo X.-L. 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/16 Cancer  Galectin-3  Inflammatory cytokines  Ras/MAPK pathway  Regulation mechanism  Transcription factors   MiR-34a Inhibits Breast Cancer Proliferation and Progression by Targeting Wnt1 in Wnt/β-Catenin Signaling Pathway 期刊论文 The American Journal of the Medical Sciences, 2016, 卷号: 352, 期号: 2, 页码: 191-199 作者:  Wentao.Si;  Yulin.Li;  Hongmin.Shao;  Rongrong.Hu;  Wen.Wa 收藏  |  浏览/下载：6/0  |  提交时间：2019/12/16 Breast cancer  microRNA-34a  Wnt1  Wnt/beta-catenin signaling pathway  Xenograft model   Gemcitabine Plus Vinorelbine as Second-Line Therapy in Patients With Metastatic Esophageal Cancer Previously Treated With Platinum-Based Chemotherapy 期刊论文 ONCOLOGY RESEARCH, 2016, 卷号: 24, 期号: 2, 页码: 129-135 作者:  Wang, Yue-shen;  Tian, Jing;  Han, Yong;  Han, Shu-mei;  Shi, Sheng-bin 收藏  |  浏览/下载：1/0  |  提交时间：2019/12/16 Advanced esophageal cancer  Second-line treatment  Gemcitabine plus  vinorelbine  Platinum-based chemotherapy  miRNA-214  Progression-free  survival   Molecular regulation of galectin-3 expression and therapeutic implication in cancer progression 期刊论文 BIOMEDICINE & PHARMACOTHERAPY, 2016, 卷号: 78, 页码: 165-171 作者:  Wang, Lei;  Guo, Xiu-Li 收藏  |  浏览/下载：7/0  |  提交时间：2019/12/16 Galectin-3  Regulation mechanism  Transcription factors  Inflammatory  cytokines  Ras/MAPK pathway  Cancer   Over-expression of lncRNA SBF2-AS1 is associated with advanced tumor progression and poor prognosis in patients with non-small cell lung cancer 期刊论文 EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2016, 卷号: 20, 期号: 14, 页码: 3031-3034 作者:  Zhao, Q. -S.;  Li, L.;  Zhang, L.;  Meng, X. -W.;  Li, L. -L. 收藏  |  浏览/下载：21/0  |  提交时间：2019/12/16 Long non-coding RNA  SBF2-AS1  Non small cell lung cancer  Prognosis   Upregulation and activation of delta-opioid receptors promotes the progression of human breast cancer 期刊论文 ONCOLOGY REPORTS, 2016, 卷号: 36, 期号: 5, 页码: 2579-2586 作者:  Wei, Yang-Chao;  Zhang, Bin;  Li, Xuan;  Liu, Xiao-Meng;  Zhang, Jing 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/16 breast cancer  delta-opioid receptor  cell cycle  apoptosis  G  protein-coupled receptor   Prediction of biomarkers of therapeutic effects of patients with lung adenocarcinoma treated with gefitinib based on progression-free-survival by metabolomic fingerprinting 期刊论文 TALANTA, 2016, 卷号: 160, 页码: 636-644 作者:  Zhuang, Jingcong;  Tang, Xiaohu;  Du, Zhenxia;  Yang, Ming;  Zhou, Ying 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/16 Biomarker  Gefitinib  Lung cancer  Metabolomics  Ultra-high performance  liquid chromatography-quadrupole-time of flight mass spectrometry  (UHPLC-Q-TOF MS)